Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Exocrine pancreatic function following pancreatectomy.

P Ghaneh1, J P Neoptolemos

  • 1Department of Surgery, Royal Liverpool University Hospital, UK.

Annals of the New York Academy of Sciences
|July 23, 1999
PubMed
Summary

Pancreatic exocrine insufficiency causes fat malabsorption and steatorrhea after major pancreatic surgery. Current enzyme supplements are insufficient, indicating a need for new therapies to manage persistent steatorrhea.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

GATA6 immunohistochemistry and prognosis after surgical resection of pancreatic adenocarcinoma: results from the ESPAC-4 trial.

ESMO gastrointestinal oncology·2026
Same author

The NEONAX study.

Annals of oncology : official journal of the European Society for Medical Oncology·2023
Same author

Linking COVID-19 and Acute Pancreatitis Through the Pathogenic Effects of the SARS-CoV-2 S Protein Subunit 1 on Pancreatic Stellate Cells and Macrophages.

Function (Oxford, England)·2022
Same author

Impaired autophagy increases susceptibility to endotoxin-induced chronic pancreatitis.

Cell death & disease·2020
Same author

[Neoadjuvant and adjuvant treatment of pancreatic cancer].

Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen·2020
Same author

Prognostic Nomogram for Resected Pancreatic Adenocarcinoma: A TRIPOD-Compliant Retrospective Long-Term Survival Analysis.

World journal of surgery·2020

Area of Science:

  • Gastroenterology
  • Surgical Oncology
  • Digestive Diseases

Background:

  • Pancreatic exocrine insufficiency (PEI) is a common complication following major pancreatic resections.
  • PEI leads to fat malabsorption, manifesting as steatorrhea, abdominal pain, and weight loss.
  • The severity of malabsorption correlates with the underlying disease and extent of surgery.

Purpose of the Study:

  • To evaluate the efficacy of current oral pancreatic enzyme supplements in managing steatorrhea postpancreatectomy.
  • To identify the limitations of existing treatments for post-surgical steatorrhea.
  • To highlight the unmet need for novel therapeutic strategies.

Main Methods:

  • Review of existing literature on steatorrhea treatment postpancreatectomy.

Related Experiment Videos

  • Analysis of randomized controlled trials assessing oral pancreatic enzyme supplementation.
  • Assessment of patient outcomes regarding steatorrhea severity.

    • Main Results:

    • A significant proportion of patients (over one-third) continue to experience substantial steatorrhea despite optimal oral pancreatic enzyme supplementation.
    • Current enzyme therapies demonstrate limited efficacy in completely eliminating steatorrhea.
    • Treatment response varies based on individual patient factors and surgical extent.

    Conclusions:

    • Complete elimination of steatorrhea following major pancreatic resection is not achievable with current therapies.
    • There is a critical need for the development of more effective treatments for managing steatorrhea in postpancreatectomy patients.
    • Further research into novel therapeutic approaches is warranted to improve patient outcomes.